Advanced search
Publication Cover
Future Oncology Volume 18, 2022 - Issue 25
Submit an article Journal homepage
204
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trial

Raj Satkunasivam1 Center for Outcomes Research,Houston Methodist Hospital,Houston,TX 77030,USA;2 Department of Urology,Houston Methodist Hospital,Houston,TX 77030,USACorrespondence[email protected]
View further author information
,
Kelvin Lim2 Department of Urology,Houston Methodist Hospital,Houston,TX 77030,USAORCID Iconhttps://orcid.org/0000-0002-8841-8676View further author information
ORCID Icon,
Bin S Teh3 Department of Radiation Oncology,Houston Methodist Hospital,Houston,TX 77030,USAView further author information
,
Jonathan Guzman2 Department of Urology,Houston Methodist Hospital,Houston,TX 77030,USA;4 Department of Urology,Lenox Hill Hospital,New York,NY 10075,USAView further author information
,
Jun Zhang5 Department of Medical Oncology,Houston Methodist Cancer Center,Houston,TX 77030,USAView further author information
,
Andrew Farach3 Department of Radiation Oncology,Houston Methodist Hospital,Houston,TX 77030,USAView further author information
,
Shu-Hsia Chen6 Center for Immunotherapy Research,Houston Methodist Research Institute,Houston,TX 77030,USAView further author information
,
Christopher JD Wallis7 Division of Urology,University of Toronto,Toronto,ON M5G 1E2,Canada;8 Division of Urology,Mount Sinai Hospital,Toronto,ON M5G 1X5,CanadaView further author information
,
Eleni Efstathiou5 Department of Medical Oncology,Houston Methodist Cancer Center,Houston,TX 77030,USAView further author information
,
Nestor F Esnaola9 Department of Surgical Oncology,Houston Methodist Hospital,Houston,TX 77030,USAView further author information
&
Guru P Sonpavde10 Department of Genitourinary Medical Oncology,Dana-Farber Cancer Institute,Boston,MA 02215,USAView further author information
 show all
Pages 2771-2781 | Received 12 Apr 2022, Accepted 01 Jun 2022, Published online: 15 Jun 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.